Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04429451 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PSMA-specific CAR-T Cell Therapy

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 31, 2029 → Dec 31, 2029
See other at-risk trials from Shenzhen Geno-Immune Medical Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2026 to Dec 31, 2026v4 Show 4 more changesShow less
    • Trial status changed: Recruiting → Not Yet Recruiting
    • Primary completion pushed from Oct 31, 2029 to Dec 31, 2029
    • Study description expanded, about 66 words
    • Site details revised
  2. Study sites: 3 to 1
    • Collaborators shortened, about 14 words
    v3
  3. Primary completion date: Oct 31, 2023 to Oct 31, 2029v2 Show 4 more changesShow less
    • Start date: Jan 1, 2020 to Jun 1, 2026
    • Study sites: 4 to 3
    • Study completion date: Dec 31, 2024 to Dec 31, 2030
    • Collaborators: 3 to 2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of PSMA-specific CAR-T cell therapy in patients with PSMA positive tumor. Another goal of the study is to learn more about the function of the PSMA CAR-T cells and their persistency in the patients.
Trial Details
NCT Number NCT04429451
Lead Sponsor Shenzhen Geno-Immune Medical Institute
Conditions
(from sponsor)		 PSMA Positive Tumors or Tumor Tissues
Related terms Prostatic Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov